Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EFFECT OF DIPHENYLHYDANTOIN ON CORTISOL METABOLISM IN MAN.

Literature DB >> 14207774

EFFECT OF DIPHENYLHYDANTOIN ON CORTISOL METABOLISM IN MAN.

Abstract

Entities: Chemical Species

Keywords: 17-HYDROXYCORTICOSTEROIDS; 17-KETOSTEROIDS; DIPHENYLHYDANTOIN; GLUCURONIDASE; HYDROCORTISONE; METABOLISM; PHARMACOLOGY; URINE

Mesh：

Substances：

Year: 1964 PMID： 14207774 PMCID： PMC441983 DOI： 10.1172/JCI105056

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

26 in total

1. Inhibition of cortisol metabolism in the liver by other steroids.

Authors: A KUMAGAI; M OTOMO; S YANO; N TAKEUCHI; K NISHINO; H UEDA; S KO; M KITAMURA
Journal: Endocrinol Jpn Date: 1959-06

2. 6beta-Hydroxycortisol and other polar corticosteroids: measurement and significance in human urine.

Authors: A G FRANTZ; F H KATZ; J W JAILER
Journal: J Clin Endocrinol Metab Date: 1961-10 Impact factor: 5.958

3. Sex difference in rate of ring A reduction of delta 4-3-keto-steroids in vitro by rat liver.

Authors: F E YATES; A L HERBST; J URQUHART
Journal: Endocrinology Date: 1958-12 Impact factor: 4.736

4. The metabolic fate of diphenylhydantoin in the dog, rat and man.

Authors: E W MAYNERT
Journal: J Pharmacol Exp Ther Date: 1960-11 Impact factor: 4.030

5. The physiologic significance of 6beta-hydroxycortisol in human corticoid metabolism.

Authors: F H KATZ; M M LIPMAN; A G FRANTZ; J W JAILER
Journal: J Clin Endocrinol Metab Date: 1962-01 Impact factor: 5.958

6. The metabolic conversion of 5, 5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin.

Authors: T C BUTLER
Journal: J Pharmacol Exp Ther Date: 1957-01 Impact factor: 4.030

7. The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

Authors: R H SILBER; C C PORTER
Journal: J Biol Chem Date: 1954-10 Impact factor: 5.157

8. The determination of urinary steroids. I. The preparation of pigment-free extracts and a simplified procedure for the estimation of total 17-ketosteroids.

Authors: I J DREKTER; A HEISLER; G R SCISM; S STERN; S PEARSON; T H McGAVACK
Journal: J Clin Endocrinol Metab Date: 1952-01 Impact factor: 5.958

9. Effects of diphenylhydantoin (dilantin) on adrenal cortical function; a study in nonepileptic human subjects.

Authors: P J COSTA; G H GLASER; D D BONNY-CASTLE
Journal: AMA Arch Neurol Psychiatry Date: 1955-07

10. The urinary excretion of tetrahydrocortisol, 3 alpha-allotetrahydrocortisol and tetrahydrocortisone in young and elderly men and women.

Authors: L P ROMANOFF; R M RODRIGUEZ; J M SEELYE; C PARENT; G PINCUS
Journal: J Clin Endocrinol Metab Date: 1958-11 Impact factor: 5.958

31 in total

Review 7. Anticonvulsant pharmacokinetics.

Authors: A Breckenridge
Journal: Proc R Soc Med Date: 1974-01

EFFECT OF DIPHENYLHYDANTOIN ON CORTISOL METABOLISM IN MAN.

1. Inhibition of cortisol metabolism in the liver by other steroids.

2. 6beta-Hydroxycortisol and other polar corticosteroids: measurement and significance in human urine.

3. Sex difference in rate of ring A reduction of delta 4-3-keto-steroids in vitro by rat liver.

4. The metabolic fate of diphenylhydantoin in the dog, rat and man.

5. The physiologic significance of 6beta-hydroxycortisol in human corticoid metabolism.

6. The metabolic conversion of 5, 5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin.

7. The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

8. The determination of urinary steroids. I. The preparation of pigment-free extracts and a simplified procedure for the estimation of total 17-ketosteroids.

9. Effects of diphenylhydantoin (dilantin) on adrenal cortical function; a study in nonepileptic human subjects.

10. The urinary excretion of tetrahydrocortisol, 3 alpha-allotetrahydrocortisol and tetrahydrocortisone in young and elderly men and women.

1. The clinical consequences of chronic hepatic enzyme induction by anticonvulsant drugs.

Review 2. Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation.

3. Pharmacokinetics and endocrine effects of terguride in healthy subjects.

4. Effects of enzyme induction on metabolism of prednisolone. Clinical and laboratory study.

Review 5. Pharmacokinetic drug interactions with phenytoin (Part II).

Review 6. Drug interactions that matter. A critical reappraisal.

Review 7. Anticonvulsant pharmacokinetics.

Review 8. Recent progress in epilepsy. Diagnostic procedures and treatment.

Review 9. Pharmacokinetic interactions with antiepileptic drugs.

10. Effect of diphenylhydantoin on patterns of insulin secretion in obese subjects.